biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by bfwon Jul 17, 2018 1:16pm

158 Views

Post# 28327776

RE:$0.435 bid

drjekyl wrote: do you guys really think that $0.55 financing will close with the current bid? if we all believe share price doesn't matter then i guess my comments are moot.

drj!

Depends on how you value the 69 cent warrant with no acceleration clause and good for 5 years.

That is some huge leverage.

Overall, I'm pretty sure management feels they can close it if they are going the non-brokered route.

bfw

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta